| Endostatin: an endogenous inhibitor of angiogenesis and tumor growth MS O'Reilly, T Boehm, Y Shing, N Fukai, G Vasios, WS Lane, E Flynn, ... cell 88 (2), 277-285, 1997 | 6695 | 1997 |
| Thalidomide is an inhibitor of angiogenesis. RJ D'Amato, MS Loughnan, E Flynn, J Folkman Proceedings of the National Academy of Sciences 91 (9), 4082-4085, 1994 | 3366 | 1994 |
| Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E–deficient mice KS Moulton, E Heller, MA Konerding, E Flynn, W Palinski, J Folkman Circulation 99 (13), 1726-1732, 1999 | 988 | 1999 |
| Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and taxol N Klauber, S Parangi, E Flynn, E Hamel, RJ D'Amato Cancer research 57 (1), 81-86, 1997 | 797 | 1997 |
| Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate MJ Tolentino, JW Miller, ES Gragoudas, FA Jakobiec, E Flynn, ... Ophthalmology 103 (11), 1820-1828, 1996 | 711 | 1996 |
| Curcumin is an in vivo inhibitor of angiogenesis JL Arbiser, N Klauber, R Rohan, R van Leeuwen, MT Huang, C Fisher, ... Molecular medicine 4, 376-383, 1998 | 647 | 1998 |
| Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways JL Arbiser, MA Moses, CA Fernandez, N Ghiso, Y Cao, N Klauber, ... Proceedings of the National Academy of Sciences 94 (3), 861-866, 1997 | 626 | 1997 |
| A model of angiogenesis in the mouse cornea. BM Kenyon, EE Voest, CC Chen, E Flynn, J Folkman, RJ D'Amato Investigative ophthalmology & visual science 37 (8), 1625-1632, 1996 | 553 | 1996 |
| 2-Methoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polymerization by interacting at the colchicine site. RJ D'Amato, CM Lin, E Flynn, J Folkman, E Hamel Proceedings of the National Academy of Sciences 91 (9), 3964-3968, 1994 | 539 | 1994 |
| A model of human tumor dormancy: an angiogenic switch from the nonangiogenic phenotype GN Naumov, E Bender, D Zurakowski, SY Kang, D Sampson, E Flynn, ... Journal of the National Cancer Institute 98 (5), 316-325, 2006 | 514 | 2006 |
| Expression of angiostatin cDNA in a murine fibrosarcoma suppresses primary tumor growth and produces long-term dormancy of metastases. Y Cao, MS O'Reilly, B Marshall, E Flynn, RW Ji, J Folkman The Journal of clinical investigation 101 (5), 1055-1063, 1998 | 391 | 1998 |
| Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer CJ Kuo, F Farnebo, EY Yu, R Christofferson, RA Swearingen, R Carter, ... Proceedings of the National Academy of Sciences 98 (8), 4605-4610, 2001 | 371 | 2001 |
| Continuous administration of endostatin by intraperitoneally implanted osmotic pump improves the efficacy and potency of therapy in a mouse xenograft tumor model O Kisker, CM Becker, D Prox, M Fannon, R D’Amato, E Flynn, WE Fogler, ... Cancer Research 61 (20), 7669-7674, 2001 | 361 | 2001 |
| Phosphoglycerate kinase acts in tumour angiogenesis as a disulphide reductase AJ Lay, XM Jiang, O Kisker, E Flynn, A Underwood, R Condron, PJ Hogg Nature 408 (6814), 869-873, 2000 | 334 | 2000 |
| Troponin I is present in human cartilage and inhibits angiogenesis MA Moses, D Wiederschain, I Wu, CA Fernandez, V Ghazizadeh, ... Proceedings of the National Academy of Sciences 96 (6), 2645-2650, 1999 | 297 | 1999 |
| Critical components of the female reproductive pathway are suppressed by the angiogenesis inhibitor AGM-1470 N Klauber, RM Rohan, E Flynn, RJ D'amato Nature medicine 3 (4), 443-446, 1997 | 267 | 1997 |
| Selective cultivation of human melanocytes from newborn and adult epidermis BA Gilchrest, MA Vrabel, E Flynn, G Szabo Journal of Investigative Dermatology 83 (5), 370-376, 1984 | 229 | 1984 |
| VASCULAR ENDOTHELIAL GROWTH FACTOR EXPRESSION AND TUMOR ANGIOGENESIS ARE REGULATED BY ANDROGENS IN HORMONE RESPONSIVE HUMAN PROSTATE CARCINOMA:: EVIDENCE FOR ANDROGEN DEPENDENT … RJ STEWART, D PANIGRAHY, E FLYNN, J FOLKMAN The Journal of urology 165 (2), 688-693, 2001 | 201 | 2001 |
| A peptide trivalent arsenical inhibits tumor angiogenesis by perturbing mitochondrial function in angiogenic endothelial cells AS Don, O Kisker, P Dilda, N Donoghue, X Zhao, S Decollogne, ... Cancer cell 3 (5), 497-509, 2003 | 196 | 2003 |
| Vitamin D binding protein-macrophage activating factor (DBP-maf) inhibits angiogenesis and tumor growth in mice O Kisker, S Onizuka, CM Becker, M Fannon, E Flynn, R D'Amato, B Zetter, ... Neoplasia 5 (1), 32-40, 2003 | 178 | 2003 |
